Two panelists represent AReNA at Leyton Connect’s 5-to-7
March 6, 2025
On March 4, 2025, Xavier Linker, Director of Strategic Initiatives at AReNA, as well as Sam Osseiran, PhD, RNA Entrepreneurship Director (Axelys), participated as panelists at the Leyton Connect 5-to-7: RNA Technologies – Beyond COVID Vaccines.
Alongside Claude LeDuc (RNA Technologies and Therapeutics), George Elvira (Gowling WLG) and Giovanna Sebastiani McGill University D2R | de l’ADN à l’ARN,, insightful discussions took place around key topics:
- Beyond COVID vaccines: What are the different RNA technologies?
- RNA industry players: Who is shaping this sector in Quebec and Canada?
- Academia & industry: A new paradigm for collaboration?
- Intellectual property: Are new ways of thinking emerging?
- Funding & competitiveness: What strategies can position Quebec and Canada on the global stage?
